Yannis P Pitsiladis

Professor of Sport and Exercise Science, University of Brighton

Yannis has an established history of research into the importance of lifestyle and genetics for human health and performance. Before joining the University of Brighton, where he also directs the FIMS Reference Collaborating Centre of Sports Medicine, he spent fifteen years at the University of Glasgow, where he created the largest known DNA biobank from world-class athletes. His current research into the use of drugs in sport is funded by the World Anti-Doping Agency. He is a member of the International Olympic Committee’s Medical and Scientific Commission and chairs the Scientific Commission of the International Sports Medicine Federation. He is a Fellow of the American College of Sports Medicine and an expert committee pool member of the Biotechnology and Biological Sciences Research Council.

Back to speakers
Back to programme

Elevating elite performance without drugs – personalisation and the digital revolution in sport

There is a widespread belief among those involved in elite sport that peak performance can only be achieved by using prohibited substances and methods. Yannis maintains the only way to counter this belief is to demonstrate alternative ways, through sports science and medicine, to elevate performance without breaking the rules. The way forward, he suggests, is to use predictive diagnostics, digital technologies and data analytics to create personalised training, nutrition and preparation regimes that allow individual athletes to raise their game to the ultimate. Here he gives an overview of what could be achieved and how technological advances could benefit athletes and audiences alike.

  • Adopting AI – from machine learning to deep learning, how data unlocks performance
  • A basis for decisions – how athletes, coaches, physicians and sports scientists can use data to achieve the ultimate
  • Intelligent anti-doping – one happy side effect of a data driven approach
  • Audience participation – increasing entertainment value by transmitting real time performance data during athletic broadcasts
  • Overcoming objections – what tech companies must do to rebuild the credibility of wearable devices and diagnostic techniques